Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-11

FDA Approved: GLIPIZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application from Aurobindo Pharma Limited for glipizide, enabling the marketing of a generic version of the drug. This action ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)